Clinical perspectives on dose escalation for non-small-cell lung cancer

Keyphrases

• Survival Rate 100%
• Dose Escalation 100%
• Non-small Cell Lung Cancer (NSCLC) 100%
• Clinical Perspective 100%
• Clinical Outcomes 50%
• United States 50%
• Failure Rate 50%
• Standard of Care 50%
• Chemotherapy 50%
• Cancer Mortality 50%
• Lung Cancer 50%
• Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) 50%
• Prescription Drugs 50%
• Concurrent Chemotherapy 50%
• Median Survival 50%
• Improved Survival 50%
• Local Failure 50%
• Treatment Volume 50%
• Cancer Causes 50%
• High-dose Radiation 50%
• Conformality 50%
• Escalating Dose 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Survival Rate 100%
• Chemotherapy 100%
• Non Small Cell Lung Cancer 100%
• Cancer Mortality 50%
• Lung Cancer 50%

Medicine and Dentistry

• Survival Rate 100%
• Non Small Cell Lung Cancer 100%
• Lung Cancer 50%
• Cancer Mortality 50%